Correction

Interferon Alfa-2b Therapy for Life-Threatening Hemangiomas of Infancy

N Engl J Med 1994; 330:300January 27, 1994

Article

Interferon Alfa-2b Therapy for Life-Threatening Hemangiomas of Infancy (Original Article, N Engl J Med 1992:326;1456 - 1463) . Table 1 contained several errors; the authors have therefore submitted a corrected Table 1Table 1Patients' Characteristics and Outcome of Interferon Alfa-2a Treatment., shown here.

Citing Articles (5)

Citing Articles

1. 1

   Tinte Itinteang, Aaron H. J. Withers, Philip Leadbitter, Darren J. Day, Swee Thong Tan. (2011) Pharmacologic Therapies for Infantile Hemangioma: Is There a Rational Basis?. Plastic and Reconstructive Surgery 128:2, 499-507
   CrossRef

2. 2

   Edith Orion, Hagit Matz, Ronni Wolf. (2002) Interferons: unapproved uses, dosages, or indications. Clinics in Dermatology 20:5, 493-504
   CrossRef

3. 3

   F BLEI. (1999) New clinical observations in hemangiomas. Seminars in Cutaneous Medicine and Surgery 18:3, 187-194
   CrossRef

4. 4

   J Folkman. (1996) New perspectives in clinical oncology from angiogenesis research. European Journal of Cancer 32:14, 2534-2539
   CrossRef

5. 5

   Ezekowitz, Alan, Mulliken, John, Folkman, Judah, . (1995) Additional Corrections: Interferon for Hemangiomas of Infancy. New England Journal of Medicine 333:9, 595-596
   Full Text

Letters